Scientific Sessions 2025  /  Biological and Pragmatic Interventions in Heart Failure: From Present to Future  /  Discussant: ANSWER-HF
Logo

American Heart Association

  45
  0

Final ID:

Discussant: ANSWER-HF

  • Pfeffer, Marc  ( BRIGHAM and WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Solomon, Scott  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Lopes, Renato  ( DUKE CLINICAL RESEARCH , Durham , North Carolina , United States )
    • Author Disclosures:
    Marc Pfeffer: DO have relevant financial relationships ; Consultant:Alexion:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Jazz:Past (completed) ; Consultant:Intellia:Active (exists now) ; Individual Stocks/Stock Options:DalCor:Active (exists now) ; Consultant:DalCor:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) | Scott Solomon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos/BridgeBio, Gossamer, GSK, Ionis, Lilly,NIH/NHLBI, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, US2.AI:Active (exists now) ; Consultant:Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, Askbio, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, GSK, Intellia, Lilly, Novartis, Roche, Theracos, Quantum Genomics, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, Valo, Synhale, Recordati:Active (exists now) | Renato Lopes: DO have relevant financial relationships ; Consultant:Pfizer:Active (exists now) ; Consultant:Medtronic:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Research Funding (PI or named investigator):Bristol Myers Squibb:Past (completed) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Bayer:Past (completed) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Daiichi Sankyo:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Biological and Pragmatic Interventions in Heart Failure: From Present to Future

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
ANSWER-HF: A Randomized Controlled Trial of Sacubitril/Valsartan Versus Enalapril in Patients with Chronic Chagas Cardiomyopathy and Reduced Ejection Fraction

Madrini Junior Vagner, Antunes Talita, Damiani Lucas, Jose Grupi Cesar, Mathias Junior Wilson, Lopes Renato, Ramires Felix, Ramos Souza Paulo, Fernandes Fabio, Maria Ianni Barbara, Silva Martins Alan, JadÁn Luzuriaga Georgina Del Cisne, Cardoso Barbosa Fonseca Keila, Ribeiro Orlando, Bispo Da Cruz Allecineia

Discussant: COPILOT HF

Van Spall Harriette

More abstracts from these authors:
Optimal Anti-Thrombotic Therapy in Acute MI

Lopes Renato

The Arc of Heart Failure

Pfeffer Marc

You have to be authorized to contact abstract author. Please, Login
Not Available